Agomab Therapeutics NV (AGMB): SCHEDULE 13D filed Feb 17, 2026

Form type

SCHEDULE 13D

Filing date

Feb 17, 2026

Accession number

0001193125-26-052946

Filer

Agomab Therapeutics NV (CIK 2020932)